Transdermal Obesity Formulations

About Skinvisible Pharmaceuticals

Skinvisible Pharmaceuticals is a drug delivery technology company leveraging its proprietary Invisicare® polymer platform to create enhanced topical and transdermal formulations. Its pipeline is strategically focused on dermatology, rare skin diseases, and the high-growth obesity/metabolic health market, aiming to provide needle-free alternatives to injections. The company follows a capital-light, partnership-driven business model, licensing its technology to development and commercial partners, as evidenced by its active collaboration with Quoin Pharmaceuticals for Netherton Syndrome.

Therapeutic Areas